HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo.

Abstract
A number of studies have shown that various K vitamins, specifically vitamins K2 and K3, possess antitumor activity on various types of rodent- and human-derived neoplastic cell lines. In the present study, we examined the antitumor effects of vitamins K1, K2 and K3 on PLC/PRF/5 human hepatocellular carcinoma (HCC) cells in vitro and in vivo. Furthermore, we examined the mechanisms of antitumor actions of these vitamins in vitro and in vivo. Although vitamin K1 did not inhibit proliferation of PLC/PRF/5 cells at a 90-microM concentration (the highest tested), vitamins K2 and K3 suppressed proliferation of the cells at concentrations of 90 and 9 microM, respectively. By flow cytometric analysis, it was shown that not only vitamin K1, but also vitamin K2 did not induce apoptosis or cell cycle arrest on PLC/PRF/5 cells. In contrast, vitamin K3 induced G1 arrest, but not apoptosis on PLC/PRF/5 cells. Subsequent in vivo study using subcutaneous HCC-bearing athymic nude mice demonstrated that both vitamins K2 and K3 markedly suppressed the growth of HCC tumors to similar extent. Protein expression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4), but not p16INK4a Cdk inhibitor in the tumor was significantly reduced by vitamin K2 or K3 treatment, indicating that vitamins K2 and K3 may induce G1 arrest of cell cycle on PLC/PRF/5 cells in vivo. Taken collectively, vitamins K2 and K3 were able to induce potent antitumor effects on HCC in vitro and in vivo, at least in part, by inducing G1 arrest of the cell cycle. The results indicate that vitamins K2 and K3 may be useful agents for the treatment of patients with HCC.
AuthorsMisuzu Hitomi, Fumi Yokoyama, Yuko Kita, Takako Nonomura, Tsutomu Masaki, Hitoshi Yoshiji, Hideyuki Inoue, Fumihiko Kinekawa, Kazutaka Kurokohchi, Naohito Uchida, Seishiro Watanabe, Shigeki Kuriyama
JournalInternational journal of oncology (Int J Oncol) Vol. 26 Issue 3 Pg. 713-20 (Mar 2005) ISSN: 1019-6439 [Print] Greece
PMID15703828 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antifibrinolytic Agents
  • Vitamin K 2
  • Vitamin K 3
  • Vitamin K 1
Topics
  • Animals
  • Antifibrinolytic Agents (pharmacology)
  • Carcinoma, Hepatocellular (pathology)
  • Cell Cycle (drug effects)
  • Drug Screening Assays, Antitumor
  • Flow Cytometry
  • Humans
  • Liver Neoplasms (pathology)
  • Mice
  • Mice, Nude
  • Transplantation, Heterologous
  • Tumor Cells, Cultured
  • Vitamin K 1 (pharmacology)
  • Vitamin K 2 (pharmacology)
  • Vitamin K 3 (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: